Helen Sheldon
Helen Sheldon
Verified email at
Cited by
Cited by
hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer
C Camps, FM Buffa, S Colella, J Moore, C Sotiriou, H Sheldon, AL Harris, ...
Clinical cancer research 14 (5), 1340-1348, 2008
New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes
H Sheldon, E Heikamp, H Turley, R Dragovic, P Thomas, CE Oon, R Leek, ...
Blood, The Journal of the American Society of Hematology 116 (13), 2385-2394, 2010
microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer
FM Buffa, C Camps, L Winchester, CE Snell, HE Gee, H Sheldon, ...
Cancer research 71 (17), 5635-5645, 2011
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
HE Gee, FM Buffa, C Camps, A Ramachandran, R Leek, M Taylor, M Patil, ...
British journal of cancer 104 (7), 1168-1177, 2011
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
S Behjati, PS Tarpey, H Sheldon, I Martincorena, P Van Loo, G Gundem, ...
Nature genetics 46 (4), 376-379, 2014
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In VivoRole of DLL4 in Tumor Resistance to Anti-VEGF Therapy
JL Li, RCA Sainson, CE Oon, H Turley, R Leek, H Sheldon, E Bridges, ...
Cancer research 71 (18), 6073-6083, 2011
MicroRNA-10b and breast cancer metastasis
HE Gee, C Camps, FM Buffa, S Colella, H Sheldon, JM Gleadle, ...
Nature 455 (7216), E8-E9, 2008
Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation‐promoting factors
H Sheldon, M Andre, JA Legg, P Heal, JM Herbert, R Sainson, ...
The FASEB Journal 23 (2), 513-522, 2009
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A
M Mura, RK Swain, X Zhuang, H Vorschmitt, G Reynolds, S Durant, ...
Oncogene 31 (3), 293-305, 2012
Intracellular movement of green fluorescent protein–tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling
H Gillham, MCHM Golding, R Pepperkok, WJ Gullick
The Journal of cell biology 146 (4), 869-880, 1999
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
M Morotti, E Bridges, A Valli, H Choudhry, H Sheldon, S Wigfield, N Gray, ...
Proceedings of the National Academy of Sciences 116 (25), 12452-12461, 2019
Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation
SN Dos Santos, H Sheldon, JX Pereira, C Paluch, EM Bridges, ...
Oncotarget 8 (30), 49484, 2017
Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4
U Harjes, E Bridges, KM Gharpure, I Roxanis, H Sheldon, F Miranda, ...
Oncogene 36 (7), 912-921, 2017
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab
MI Koukourakis, A Giatromanolaki, H Sheldon, FM Buffa, G Kouklakis, ...
Clinical Cancer Research 15 (22), 7069-7076, 2009
A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis
G Kerr, H Sheldon, A Chaikuad, I Alfano, F von Delft, AN Bullock, ...
Angiogenesis 18 (2), 209-217, 2015
Copper chelator ATN-224 inhibits endothelial function by multiple mechanisms
SA Lowndes, HV Sheldon, S Cai, JM Taylor, AL Harris
Microvascular research 77 (3), 314-326, 2009
Glutamine deprivation alters the origin and function of cancer cell exosomes
SJ Fan, B Kroeger, PP Marie, EM Bridges, JD Mason, K McCormick, ...
The EMBO journal 39 (16), e103009, 2020
Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer
W Leung, I Roxanis, H Sheldon, FM Buffa, JL Li, AL Harris, A Kong
Oncotarget 6 (8), 5678, 2015
Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with …
L Mavroeidis, H Sheldon, E Briasoulis, M Marselos, P Pappas, AL Harris
International Journal of Oncology 47 (2), 455-464, 2015
Development of a new bimodal imaging methodology: a combination of fluorescence microscopy and high‐resolution secondary ion mass spectrometry
KH Lau, M Christlieb, M Schröder, H Sheldon, AL Harris, CRM Grovenor
Journal of microscopy 240 (1), 21-31, 2010
The system can't perform the operation now. Try again later.
Articles 1–20